Hyperbaric Oxygen Therapy — What It Is and Does It Work?

One of the best-studied applications of HBOT is treating chronic, non-healing wounds — particularly diabetic foot ulcers, where poor blood flow and chronic tissue hypoxia significantly hinder natural healing processes. This application has the largest number of randomized clinical trials of any HBOT indication.

This is a result with real clinical significance: reducing the risk of major amputation in patients with an advanced, non-healing diabetic wound is a hard, countable endpoint, not a subjective improvement in well-being. It's worth noting the limitations, though — heterogeneity between studies (different pressure protocols, session duration, and number of sessions) means there's no single, universal HBOT "dosing" that guarantees this effect, and the decision to use this therapy in a specific patient is made by the treating team based on the severity of the wound and overall health.

Decompression sickness (the "bends") in divers and acute carbon monoxide poisoning are historically the first and most uncontroversial indications for hyperbaric therapy, written into standard emergency protocols worldwide, including the guidelines of the Undersea and Hyperbaric Medical Society (UHMS). In decompression sickness, elevated pressure physically shrinks nitrogen bubbles that were released in tissues and blood vessels during too-rapid ascent — a purely physical mechanism, independent of the extra oxygen itself, though a high oxygen concentration additionally supports nitrogen elimination and limits damage to tissues starved by the gas embolism.

In carbon monoxide poisoning, hemoglobin binds CO more than 200 times more strongly than it binds oxygen, drastically limiting blood's ability to carry oxygen to tissues, including the brain and heart. HBOT accelerates CO elimination from hemoglobin and — just as importantly — delivers oxygen dissolved directly in plasma, partly bypassing the blocked hemoglobin. Clinical guidelines recommend HBOT primarily for severe poisoning: carboxyhemoglobin (CO-Hb) levels above 25%, loss of consciousness, or the presence of neurological and cardiac symptoms.

In 2020, an Israeli team from Tel Aviv University and Shamir Medical Center published a study that quickly became one of the most frequently cited arguments in the marketing of biohacking clinics offering HBOT as an anti-aging therapy. The results do sound spectacular — but they're worth examining closely before translating them into a practical recommendation.

The same Shamir Medical Center team has also published smaller studies suggesting a beneficial effect of HBOT on cognitive function in healthy older people and on skin aging parameters, but these are works from the same research center, with similar methodological limitations — independent replication by other research teams is needed, ideally in randomized, placebo-controlled trials, before these results can be considered solidly confirmed.

Another popular wellness application is using HBOT to speed up post-workout recovery in athletes — from amateurs to professionals. Here the evidence varies considerably depending on the specific type of injury or complaint involved.

This distinction — between a real tissue injury and routine post-workout fatigue — matters practically. An athlete recovering from a muscle tear or ligament injury has a different rationale for considering HBOT (ideally under a sports physiotherapist's supervision) than someone looking for a way to bounce back faster after an ordinary training day, where cheaper and better-studied interventions — sleep, adequate protein intake, active recovery — have stronger evidentiary support.

Beyond the direct effect of increased oxygen delivery to hypoxic tissues, researchers describe several additional mechanisms that could explain HBOT's broader effects. High tissue oxygen concentration paradoxically stimulates angiogenesis — the formation of new blood vessels — via a transient increase in oxidative stress that activates transcription factors such as HIF-1α (hypoxia-inducible factor), normally triggered in response to oxygen deprivation. This phenomenon is sometimes called the "hyperoxic paradox" — a temporary excess of oxygen triggers a cellular response similar to the one normally triggered by its deficiency.

HBOT also affects the mobilization of stem cells from bone marrow into the bloodstream and mitochondrial function, though these mechanisms are better documented in animal studies and cell models than in human clinical trials. It's precisely these mechanisms — angiogenesis, stem cell mobilization, modulation of inflammation — that provide the biological rationale for why researchers test HBOT across such a broad spectrum of applications, from wounds to cognitive function. A mechanistic rationale, however, is only the first step — plausible biology doesn't replace solid clinical trials in humans with hard endpoints.

Hyperbaric therapy for medical indications — treating chronic wounds, decompression sickness, gas embolism, or selected radiation-related complications — is available in hyperbaric medicine centers usually operating alongside larger hospitals or specialized underwater and hyperbaric medicine clinics; some procedures may be covered by public health insurance for defined indications, though it's worth verifying reimbursement rules directly with the specific center. Wellness sessions at private recovery clinics, offered to healthy people without a specific medical indication, are usually fully out-of-pocket, with a single session typically costing anywhere from modest to substantial amounts depending on the pressure protocol and the clinic's reputation.

HBOT is a rare example of an intervention where sharply different levels of evidence coexist under one marketing name. For a patient with a diabetic foot ulcer at risk of amputation, it's a well-justified adjunct medical therapy with real support from clinical research. For a healthy 40-year-old looking for a way to "slow aging," it's for now buying access to a promising hypothesis, based on one small study with no control group — not a confirmed clinical effect. Both of these things can be true at once, and that's exactly what makes this topic hard to sum up in one media-friendly sentence.